N6-Isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers

42Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Isopentenyladenosine (i6A) is a product of isopentenyltransferases and, in mammals, occurs either bound to tRNA or as a free nucleoside. Sporadic reports have suggested an anticancer effect of i 6A, mostly on leukemia cells. The present analysis of 9 human epithelial cancer cell lines derived from different types of malignant tissue revealed complete suppression of clonogenic activity in 8 of the lines after exposure to i6A at a concentration of 10 μM. Mechanistic studies showed that i6A tumor suppressor activity is associated with inhibition of cell proliferation, a block in DNA synthesis and morphological changes. These results point to i6A and to its possible derivatives as a new potential class of wide-spectrum anticancer agents. © 2007 Wiley-Liss, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Spinola, M., Colombo, F., Falvella, F. S., & Dragani, T. A. (2007). N6-Isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers. International Journal of Cancer, 120(12), 2744–2748. https://doi.org/10.1002/ijc.22601

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free